← FDA DRUG APPROVALS

FDA ANDA · ANDA211038

CALCIUM ACETATE

Sponsor: SUVEN PHARMS

APPLICATION
ANDA211038
TYPE
ANDA
ORIGINAL APPROVAL
2020-02-21
LATEST ACTION
2020-11-17
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

CALCIUM ACETATEPrescription
CALCIUM ACETATE 667MG · CAPSULE · ORAL

Approval history

2020-11-17Labeling · Supplement 2 · standardAP
2020-11-17Labeling · Supplement 1 · standardAP
2020-02-21UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →